Eligibility Matcher
Select your organization type below to see only the grants you qualify for — sorted by soonest deadline.
Native American tribal organizations (other)Nonprofits having 501(c)(3) statusNonprofits without 501(c)(3) statusPrivate institutions of higher educationIndividualsFor-profit organizationsSmall businessesOthersUnrestrictedState governmentsCounty governmentsCity or township governmentsSpecial district governmentsIndependent school districtsPublic/State controlled institutions of higher educationNative American tribal governments (Federally recognized)Public housing authorities
509 grants for Native American tribal organizations (other)
Sorted by deadline (soonest first)
Model-to-Clinic (M2C) for Precision Medicine with AI: Integrating Imaging with Multimodal Data (PRIMED-AI) (UG3/UH3, Clinical Trial Optional)
HHS-NIH11 · RFA-RM-27-013
Closes Oct 19, 2026
Nutrition Obesity Research Centers (NORCs) (P30 Clinical Trial Optional)
HHS-NIH11 · RFA-DK-27-120
Closes Oct 20, 2026
Optimizing Behavioral Sleep Interventions for Adolescents and Young Adults (R34 Clinical Trial Required)
HHS-NIH11 · RFA-MH-27-140
Closes Oct 22, 2026
Population Assessment of Tobacco and Health (PATH) Study Biospecimen Access (X01)
HHS-NIH11 · PAR-24-027
Closes Oct 30, 2026
GREGoRi Technology Integration Center (U01, Clinical Trials Optional)
HHS-NIH11 · RFA-HG-27-012
Closes Oct 30, 2026
GREGoRi Innovation Projects (U01 Clinical Trial Optional)
HHS-NIH11 · RFA-HG-27-013
Closes Oct 30, 2026
GREGoRi Data Coordination and Outreach Center (U01, Clinical Trials Not Allowed)
HHS-NIH11 · RFA-HG-27-011
Closes Oct 30, 2026
Clinical Observational (CO) Studies in Musculoskeletal, Rheumatic, and Skin Diseases (R01 Clinical Trial Not Allowed)
HHS-NIH11 · PAR-24-280
Closes Nov 2, 2026
Exploratory Clinical Trial Grants in Arthritis and Musculoskeletal and Skin Diseases (R61 Clinical Trial Required)
HHS-NIH11 · PAR-24-279
Closes Nov 2, 2026
Developing novel theory and methods for understanding the genetic architecture of complex human traits (R01 Clinical Trial Not Allowed)
HHS-NIH11 · PAR-25-255
Closes Nov 5, 2026
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R01 Clinical Trial Not Allowed)
HHS-NIH11 · PAR-25-095
Closes Nov 6, 2026
Amyotrophic Lateral Sclerosis (ALS) Intermediate Patient Population Expanded Access (U01 Clinical Trial Required)
HHS-NIH11 · RFA-NS-26-001
Closes Nov 10, 2026
Advanced Development and Validation of Emerging Technologies for Basic and Clinical Cancer Research (R33 Clinical Trial Not Allowed)
HHS-NIH11 · RFA-CA-27-002
Closes Nov 10, 2026
Early-Stage Innovative Technology Development for Basic and Clinical Cancer Research (R61 Clinical Trial Not Allowed)
HHS-NIH11 · RFA-CA-27-001
Closes Nov 10, 2026
NCCIH Natural Product Mid Phase Clinical Trial (R01 Clinical Trial Required)
HHS-NIH11 · PAR-25-271
Closes Nov 13, 2026
NCCIH Natural Product Early Phase Clinical Trial Phased Innovation Award (R61/R33 Clinical Trial Required)
HHS-NIH11 · PAR-25-269
Closes Nov 13, 2026
NIDA Mentored Clinical Scientist Development Program Award in Substance Use and Substance Use Disorder Research (K12 Clinical Trial Optional)
HHS-NIH11 · PAR-24-089
Closes Nov 13, 2026
NCCIH Natural Product Early Phase Clinical Trial Award (R33 Clinical Trial Required)
HHS-NIH11 · PAR-25-270
Closes Nov 13, 2026
Ethical, Legal and Social Implications (ELSI) Small Research Grant (R03 Clinical Trial Optional)
HHS-NIH11 · PAR-25-370
Closes Nov 16, 2026
Feasibility Clinical Trials of Mind and Body Interventions for NCCIH High Priority Research Topics (R34 Clinical Trial Required)
HHS-NIH11 · PAR-25-274
Closes Nov 17, 2026
Investigator Initiated Clinical Trials of Complementary and Integrative Interventions Delivered Remotely or via mHealth (R01 Clinical Trial Required)
HHS-NIH11 · PAR-25-268
Closes Nov 17, 2026
NCCIH Multi-Site Feasibility Clinical Trials of Mind and Body Interventions (R01 Clinical Trial Required)
HHS-NIH11 · PAR-25-267
Closes Nov 17, 2026
Prevention and Intervention Approaches for Fetal Alcohol Spectrum Disorders (R61/R33 Clinical Trial Optional)
HHS-NIH11 · PAR-25-158
Closes Nov 17, 2026
Secondary Analysis and Integration of Existing Data to Elucidate Cancer Risk and Related Outcomes (R21 Clinical Trials Not Allowed)
HHS-NIH11 · PAR-25-096
Closes Nov 17, 2026
Ethical, Legal and Social Implications (ELSI) Research (R01 Clinical Trial Optional)
HHS-NIH11 · PAR-25-371
Closes Nov 18, 2026